|
|
||||||||
Articles |
1
Merck Research Laboratories, Rahway, NJ 07065.
2
Departments of Pediatrics and Pathology, Johns Hopkins
University School of Medicine, Baltimore, MD 21287 (retired).
3
Wilford Hall Medical Center, Department of
Pathology, Lackland Air Force Base, TX 78236.
4
National Center for Environmental Health, Division of
Environmental Health Laboratory Sciences, Centers for Disease Control
and Prevention, Atlanta, GA 30341.
5
Medical Research Laboratories, Highland Heights, KY
41076.
a Address correspondence to this author at: c/o D. Bartholomew, 11 Fox Run Rd., Falmouth, ME 04105. Fax: 207-797-8596 (primary) or 410-955-1276 (secondary); e-mail pbach{at}prodigy.net
We estimated the effects of long-term storage at -70 °C on serum total cholesterol, HDL-cholesterol, and triglycerides in specimens that had been stored for up to 7 years. These estimates were made using measurements in serial specimens collected from the placebo control group of the Air Force/Texas Coronary Atherosclerosis Prevention Study over a period of ~5 years. We compared the group means for pairs of serial specimens taken at 6- and 12-month intervals, assuming that (a) a negligible placebo effect occurred between the serial specimen pairs; (b) in the absence of storage effects, the variation in the group means would reflect only normal biological variation and would not materially affect the group means for the serial specimens; (c) any systematic changes in these group means would reflect storage-related changes; and (d) storage-related changes are cumulative, i.e., the overall changes for a given storage period are the sum of the changes during previous storage periods. We observed average decreases of 2.0% per year for total cholesterol over 7 years and 2.8% per year in triglycerides for the first 5 years. HDL-cholesterol decreased by 1.3% per year, but this change was not statistically significant. This approach may be useful for estimating storage-related changes for studies in specimens stored for a period of years and for which stability data may not be available.
The following articles in journals at HighWire Press have cited this article:
![]() |
A. E Cust, R. Kaaks, C. Friedenreich, F. Bonnet, M. Laville, A. Tjonneland, A. Olsen, K. Overvad, M. U. Jakobsen, V. Chajes, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr. Relat. Cancer, September 1, 2007; 14(3): 755 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Sesso, J. E. Buring, M. J. Chown, P. M Ridker, and J. M. Gaziano A Prospective Study of Plasma Lipid Levels and Hypertension in Women Arch Intern Med, November 14, 2005; 165(20): 2420 - 2427. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Rundle, P. Vineis, and H. Ahsan Design Options for Molecular Epidemiology Research within Cohort Studies Cancer Epidemiol. Biomarkers Prev., August 1, 2005; 14(8): 1899 - 1907. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. O. Kwiterovich Jr, E. P. G. Vining, P. Pyzik, R. Skolasky Jr, and J. M. Freeman Effect of a High-Fat Ketogenic Diet on Plasma Levels of Lipids, Lipoproteins, and Apolipoproteins in Children JAMA, August 20, 2003; 290(7): 912 - 920. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |